Nanotech inhibitor for anthrax made by RPI and U. Toronto
From The Business Review (Albany), news of possibly important work on anthrax defense:
“Researchers from Rensselaer Polytechnic Institute in Troy, N.Y., and the University of Toronto have collaborated on a successful design of a nanoscale assembly of molecules that counteracts anthrax toxin in animal and lab experiments.
“The inhibitor works by preventing the assembly of toxic enzyme components, which in turn neutralizes the anthrax toxin.
“Rats were protected from anthrax in the experiment.
“The researchers said they hope to develop the inhibitor as a neutralizer for human anthrax exposure.”
May 6th, 2006 at 11:44 AM
Wouldn’t this sort of technology work on Hepatitis C? Using nanotubes as the insertion vehicle and the inhibitor combined to kill this virus? Hep C is a virus; couldn’t these technologies (nanotubes and inhibitor) be used together to form a therapy that can destroy or counteract Hep C toxins/virus? This is a huge question. The market is huge also. There are millions of people infected with this disease.